Earlier studies have revealed that in contrast to the situation in CAFs, p53 in normal fibroblasts (NFs) plays a tumor-suppressive role to restrict tumor growth.

A novel therapeutic approach uses drugs encapsulated within galacto‐oligosaccharide gel capsules to attack diseases that have assembled a high percentage of senescent cells. Senescent cells